Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q3 2020 Earnings

5AugConfirmed

Q4 2019

Q1 2020

Q2 2020

Q3 2020

-0.57

-0.47

-0.37

-0.27

Details

Expected EPS

-0.44

Actual EPS

-0.27

Surprise EPS

0.17

Surprise Percent

+38.64%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.27 per share for Q3 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.